Eudaimonia Asset Management »

Structure Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.6M 38k 69.55
2023-09-30 $2.2M 44k 50.42

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Structure Therapeutics

venBio Select Advisor
Wellington Management Company
FMR
Henderson Group
Deep Track Capital
BVF
Baker Bros. Advisors
RA Capital Management
Principal Financial Group
Millennium Management
Casdin Capital
OrbiMed Advisors
Siren
TCG Crossover Management
Driehaus Capital Management

View all funds holding Structure Therapeutics